Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis—A Pilot Study

This study assessed cardiac autonomic response to head-up tilt test (HUTT) in 23 myasthenia gravis (MG) and 23 relapsing-remitting multiple sclerosis (RRMS) patients compared to 30 healthy controls (HC). Task Force<sup>®</sup> Monitor was used to evaluate cardiac inotropy parameters, bar...

Full description

Bibliographic Details
Main Authors: Łukasz Rzepiński, Monika Zawadka-Kunikowska, Julia L. Newton, Paweł Zalewski
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/10/2173
Description
Summary:This study assessed cardiac autonomic response to head-up tilt test (HUTT) in 23 myasthenia gravis (MG) and 23 relapsing-remitting multiple sclerosis (RRMS) patients compared to 30 healthy controls (HC). Task Force<sup>®</sup> Monitor was used to evaluate cardiac inotropy parameters, baroreflex sensitivity (BRS), heart rate (HRV), and blood pressure variability (BPV) during HUTT. MG patients were characterized by reduced BRS (<i>p</i> < 0.05), post-HUTT decrease in high-frequency component (<i>p</i> < 0.05) and increase in sympathovagal ratio of HRV (<i>p</i> < 0.05) when compared to controls indicating parasympathetic deficiency with a shift of sympathovagal balance toward sympathetic predominance. Compared to HC, MG patients also showed lower cardiac inotropy parameters, specifically, left ventricular work index (LVWI) during supine rest (<i>p</i> < 0.05) as well as LVWI and cardiac index values in response to orthostatic stress (<i>p</i> < 0.01 and <i>p</i> < 0.05, respectively). Compared to controls, RRMS patients were characterized by lower HRV delta power spectral density (<i>p</i> < 0.05) and delta low-frequency HRV (<i>p</i> < 0.05) in response to HUTT suggesting combined sympathetic and parasympathetic dysfunction. There were no differences in cardiac autonomic parameters between MG and MS patients (<i>p</i> > 0.05). Our study highlights the possibility of cardiac and autonomic dysfunction in patients with MG and RRMS which should be considered in the pharmacological and rehabilitation approach to managing these conditions.
ISSN:2077-0383